These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33705977)

  • 1. Primary Needling of the Ab Interno Gelatin Microstent Reduces Postoperative Needling and Follow-up Requirements.
    Kerr NM; Lim S; Simos M; Ward T
    Ophthalmol Glaucoma; 2021; 4(6):581-588. PubMed ID: 33705977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ab-interno gelatin microstent implantation in primary and refractory glaucoma.
    Szigiato AA; Touma S; Jabbour S; Lord F; Agoumi Y; Singh H
    Can J Ophthalmol; 2023 Aug; 58(4):328-337. PubMed ID: 35339436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy outcomes of the Xen45 Gel Stent use for refractory glaucoma: a surgery series from surgeon trainees at a tertiary teaching hospital.
    Hong K; Lind J; Sheybani A
    Eye Vis (Lond); 2020; 7():5. PubMed ID: 32021876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Needling Revision After XEN Gel Stent Implantation: A Prospective Study.
    Midha N; Gillmann K; Chaudhary A; Mermoud A; Mansouri K
    J Glaucoma; 2020 Jan; 29(1):11-14. PubMed ID: 31702711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-Year Outcomes of XEN Gel Stent Surgery in Patients with Open-Angle Glaucoma.
    Mansouri K; Bravetti GE; Gillmann K; Rao HL; Ch'ng TW; Mermoud A
    Ophthalmol Glaucoma; 2019; 2(5):309-318. PubMed ID: 32672673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
    Schlenker MB; Gulamhusein H; Conrad-Hengerer I; Somers A; Lenzhofer M; Stalmans I; Reitsamer H; Hengerer FH; Ahmed IIK
    Ophthalmology; 2017 Nov; 124(11):1579-1588. PubMed ID: 28601250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma.
    Rauchegger T; Angermann R; Willeit P; Schmid E; Teuchner B
    Acta Ophthalmol; 2021 Jun; 99(4):369-375. PubMed ID: 32996702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Retrospective Analysis of Safety and Efficacy of XEN 45 Microstent Combined Cataract Surgery in Open-Angle Glaucoma over 24 Months.
    Subaşı S; Yüksel N; Özer F; Yılmaz Tugan B; Pirhan D
    Turk J Ophthalmol; 2021 Jun; 51(3):139-145. PubMed ID: 34187146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance and Safety of a New Ab Interno Gelatin Stent in Refractory Glaucoma at 12 Months.
    Grover DS; Flynn WJ; Bashford KP; Lewis RA; Duh YJ; Nangia RS; Niksch B
    Am J Ophthalmol; 2017 Nov; 183():25-36. PubMed ID: 28784554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgeon Experience as a Risk Factor for Short-Term Failure for Ab Interno Gelatin Microstent: A Canadian Multicenter Propensity-Matched Study.
    Schlenker MB; Ong JA; Wu P; Jinapriya D; Zack B; Dorey MW; Harasymowycz PJ; Ahmed IIK;
    Ophthalmol Glaucoma; 2022; 5(1):67-76. PubMed ID: 34089949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Safety and Efficacy Between Ab Interno and Ab Externo Approaches to XEN Gel Stent Placement.
    Tan NE; Tracer N; Terraciano A; Parikh HA; Panarelli JF; Radcliffe NM
    Clin Ophthalmol; 2021; 15():299-305. PubMed ID: 33531795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-World Retrospective Consecutive Study of Ab Interno XEN 45 Gel Stent Implant with Mitomycin C in Black and Afro-Latino Patients with Glaucoma: 40% Required Secondary Glaucoma Surgery at 1 Year.
    Laroche D; Nkrumah G; Ng C
    Middle East Afr J Ophthalmol; 2019; 26(4):229-234. PubMed ID: 32153335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma.
    Reitsamer H; Sng C; Vera V; Lenzhofer M; Barton K; Stalmans I;
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):983-996. PubMed ID: 30758653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate Outcomes of the Novel 63-μm Gelatin Microstent versus the Conventional 45-μm Gelatin Microstent.
    Hussein IM; De Francesco T; Ahmed IIK
    Ophthalmol Glaucoma; 2023; 6(6):580-591. PubMed ID: 37169174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of failed ab-interno trabeculectomy (trabectome) on subsequent XEN45 gel stent implantation in pseudophakic eyes.
    Kiessling D; Rennings C; Hild M; Lappas A; Dietlein TS; Roessler GF; Widder RA
    Int Ophthalmol; 2021 Dec; 41(12):4047-4053. PubMed ID: 34365554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors.
    Gillmann K; Bravetti GE; Rao HL; Mermoud A; Mansouri K
    Acta Ophthalmol; 2021 Jun; 99(4):e531-e539. PubMed ID: 32930515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of
    Sharpe R; Pham G; Chang P
    J Curr Glaucoma Pract; 2020; 14(3):87-92. PubMed ID: 33867756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing Outcomes of 45 Xen Implantation Ab Interno With Closed Conjunctiva to Ab Externo With Open Conjunctiva Approaches.
    El Helwe H; Ingram Z; Neeson CE; Falah H; Trzcinski J; Lin JB; Solá-Del Valle DA
    J Glaucoma; 2024 Feb; 33(2):116-125. PubMed ID: 37853674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study.
    Reitsamer H; Vera V; Ruben S; Au L; Vila-Arteaga J; Teus M; Lenzhofer M; Shirlaw A; Bai Z; Balaram M; Stalmans I
    Acta Ophthalmol; 2022 Feb; 100(1):e233-e245. PubMed ID: 33973370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [XEN
    Buffault J; Baudouin C; Labbé A
    J Fr Ophtalmol; 2019 Apr; 42(4):391-403. PubMed ID: 30879831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.